• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 4.0/40; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 4.0/40; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 391021
Device Problem Material Deformation (2976)
Patient Problem No Information (3190)
Event Date 07/02/2020
Event Type  malfunction  
Event Description
The orsiro drug-eluting stent system was chosen for the treatment of a calcified lesion in the lad.After pre-dilatation the orsiro was delivered to the target lesion but a stent deformation was noted during positioning.Thus the orsiro was replaced with another stent and the procedure was finished.
 
Manufacturer Narrative
The returned product was subjected to a technical analysis and the corresponding production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for this event.The technical investigation of the returned instrument revealed that the stent is severely deformed at its proximal end.Several stent struts are bent outwards.The stent has dislodged but it could be clarified that the stent was separated from its delivery system by the hospital staff after successful withdrawal of the instrument.Microscopic analysis revealed stent imprints on the exposed balloon surface, indicating that all struts were initially crimped on the balloon.Review of the production documentation confirmed that the instrument was manufactured according to specifications and passed all in-process and final inspections.As a part of final inspection every stent system undergoes visual inspection to ensure correct embedding and homogeneous crimping of the stent.Further, the stent outer diameter is verified to 100 percent.Based on the conducted investigations, no manufacturing or material related root cause could be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO 4.0/40
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key10311723
MDR Text Key199979400
Report Number1028232-2020-03022
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 07/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/22/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/07/2020
Device Model Number391021
Device Catalogue NumberSEE MODEL NO.
Device Lot Number09184472
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/21/2020
Date Manufacturer Received09/14/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-